Targeting GRK2 by gene therapy for heart failure: benefits above β-blockade von Reinkober, J, Tscheschner, H, Pleger, S T, Most, P, Katus, H A, Koch, W J, Raake, P W J

Volltext

Gene Therapy Targets in Heart Failure: The Path to Translation von Raake, P W J, Tscheschner, H, Reinkober, J, Ritterhoff, J, Katus, H A, Koch, W J, Most, P

Volltext

Cardiomyocyte-specific RXFP1 overexpression protects against pressure overload-induced cardiac dysfunction independently of relaxin von Wingert, J., Meinhardt, E., Sasipong, N., Pott, M., Lederer, C., de la Torre, C., Sticht, C., Most, P., Katus, H.A., Frey, N., Raake, P.W.J., Schlegel, P.

Volltext

Emergency interventional treatment of cardiogenic shock due to decompensated aortic stenosis: a systematic review and meta-analysis von Kuehne, S G, Raake, P W J, Chiarito, M, Bongiovanni, D

Volltext

AAV6. ARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model von Raake, P. W. J., Schlegel, P., Ksienzyk, J., Reinkober, J., Barthelmes, J., Schinkel, S., Pleger, S., Mier, W., Haberkorn, U., Koch, W. J., Katus, H. A., Most, P., Muller, O. J.

Volltext

Single-cell mass cytometry analysis unveils prothrombotic expression and heterogeneity in essential thrombocythemia von Kuehne, S G, Dill, V, Kirmes, K, Han, J, Klug, M, Bloxham, C J, Raake, P W J, Bernlochner, I, Bongiovanni, D

Volltext

Targeting GRK2 by gene therapy for heart failure: benefits above [beta]-blockade von Reinkober, J, Tscheschner, H, Pleger, S T, Most, P, Katus, H A, Koch, W J, Raake, P W J

Volltext

Aufbau und Organisation von Herzinsuffizienz-Netzwerken (HF‑NETs) und Herzinsuffizienz-Einheiten („Heart Failure Units“, HFUs) zur Optimierung der Behandlung der akuten und chronis... von Ertl, G., Angermann, C. E., Bekeredjian, R., Beyersdorf, F., Güder, G., Gummert, J., Katus, H. A., Kindermann, I., Pauschinger, M., Perings, S., Raake, P. W. J., Störk, S., Scheidt, W. von, Welz, S., Böhm, M.

Volltext

Aufbau und Organisation von Herzinsuffizienz-Netzwerken (HF‑NETs) und Herzinsuffizienz-Einheiten („Heart Failure Units“, HFUs) zur Optimierung der Behandlung der akuten und chronis... von Ertl, G, Angermann, C. E, Bekeredjian, R, Beyersdorf, F, Güder, G, Gummert, J, Katus, H. A, Kindermann, I, Pauschinger, M, Perings, S, Raake, P. W. J, Störk, S, Scheidt, W. von, Welz, S, Böhm, M

Volltext

COVID-19 among heart transplant recipients in Germany: a multicenter survey von Rivinius, Rasmus, Kaya, Ziya, Schramm, René, Boeken, Udo, Provaznik, Zdenek, Heim, Christian, Knosalla, Christoph, Schoenrath, Felix, Rieth, Andreas, Berchtold-Herz, Michael, Barten, Markus J., Rauschning, Dominic, Mücke, Victoria T., Heyl, Stephan, Pistulli, Rudin, Grinninger, Carola, Hagl, Christian, Gummert, Jan F., Warnecke, Gregor, Schulze, P. Christian, Katus, Hugo A., Kreusser, Michael M., Raake, Philip W.

Volltext

Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model von Weber, C, Neacsu, I, Krautz, B, Schlegel, P, Sauer, S, Raake, P, Ritterhoff, J, Jungmann, A, Remppis, A B, Stangassinger, M, Koch, W J, Katus, H A, Müller, O J, Most, P, Pleger, S T

Volltext

Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors von Raake, P W, Hinkel, R, Müller, S, Delker, S, Kreuzpointner, R, Kupatt, C, Katus, H A, Kleinschmidt, J A, Boekstegers, P, Müller, O J

Volltext

Recommendations on biosimilar low‐molecular‐weight heparins von HARENBERG, J., KAKKAR, A., BERGQVIST, D., BARROWCLIFFE, T., CASU, B., FAREED, J., MISMETTI, P., OFOSU, F. A., RAAKE, W., SAMAMA, M., SCHULMAN, S.

Volltext

G-protein coupled receptor kinase 2 (GRK-2), a new regulator in the pathological cardiac hypertrophy by interacting NFAT signaling von Reinkober, J., Tscheschner, H., Schlegel, P., Wieland, T., Backs, J., Koch, W., Katus, H., Most, P., Raake, P.

Volltext

Glucose-regulated protein 78 (GRP78) overexpression inhibits doxorubicin cardiotoxicity von Tscheschner, H., Reinkober, J., Most, P., Katus, H. A., Mueller, M., Mueller, O. J., Raake, P. W.

Volltext

Selective Pressure-Regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial... von von Degenfeld, Georges, Raake, Philip, Kupatt, Christian, Lebherz, Corinna, Hinkel, Rabea, Gildehaus, Franz Josef, Münzing, Wolfgang, Kranz, Andrea, Waltenberger, Johannes, Simoes, Marcus, Schwaiger, Markus, Thein, Eckart, Boekstegers, Peter

Volltext

GeneTherapy Targets in Heart Failure: The Path to Translation: Cardiovascular Health von RAAKE, Pwj, TSCHESCHNER, H, REINKOBER, J, RITTERHOFF, J, KATUS, H. A, KOCH, W. J, MOST, P

Volltext

Targeting GRK2 by gene therapy for heart failure: benefits above β-blockade: Cardiovascular Gene Therapy von REINKOBER, J, TSCHESCHNER, H, PLEGER, S. T, MOST, P, KATUS, H. A, KOCH, W. J, RAAKE, Pwj

Volltext

Endogenous Release of Tissue Factor Pathway Inhibitor by Topical Application of an Ointment Containing Mucopolysaccharide Polysulfate to Nonhuman Primates von Hoppensteadt, Debra A., Fareed, Jawed, Raake, Phillip, Raake, Wolfram

Volltext

Curriculum Herzinsuffizienz von Frey, N., Albrecht, A., Bauersachs, J., Hasenfuss, G., Laufs, U., Luchner, A., Pauschinger, M., Raake, P., Sack, S., von Scheidt, W., Schulze, C., Smetak, N., Subin, B.

Volltext